Publications

Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities

 64
Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities

Tags:

Previous Article

Modulating organelle membrane contact sites using small molecules

Next Article

Mechanisms of complement dysregulation in MS

Related Posts

Endothelial-secreted Endocan activates PDGFRA and regulates vascularity and spatial phenotype in glioblastoma

Endothelial-secreted Endocan activates PDGFRA and regul...

 91

Non-ionotropic signaling through the NMDA receptor GluN2B carboxy-terminal domain drives dendritic spine plasticity and reverses fragile X phenotypes

Non-ionotropic signaling through the NMDA receptor GluN...

 128

Spatially resolved technologies for microRNA profiling in tissues

Spatially resolved technologies for microRNA profiling ...

 128